China's top official in charge of the pandemic, Sun Chunlan, while...
Category:
Health
Latest
Working to introduce integrative medicine in all hospitals: Union Health Minister
Union Health Minister Mansukh Mandaviya The government has...
WHO releases updated guidelines on treatment of drug-resistant tuberculosis
''Building on the newly available data, we now have a better and...
More scarce than opening-night tickets: insurance to back Broadway shows
Right now most insurers, if not all, have come out with a virus or communicable disease exclusion that they’re putting on their policies,” said Peter Shoemaker, managing director of the New York entertainment division at insurance broker DeWitt Stern.
Health experts cast doubt on India’s timeline for COVID vaccine
“It is envisaged to launch the vaccine for public health use latest by August 15, 2020, after completion of all clinical trials,” ICMR Director General Balram Bhargava said in the letter, dated July 2 and addressed to institutions involved in the trials.
Coronavirus mortality in Italy is highest among poor, study shows
Low-income groups were also more likely to be forced to work during lockdown, in sectors such as agriculture, public transport and assistance for the elderly, ISTAT said, concluding that COVID-19 had “accentuated pre-existing inequalities.”
Global coronavirus cases rise to more than 11 million
The United States reported more than 55,400 new COVID-19 cases on Thursday, a new daily global record as infections rose in a majority of states. Several U.S. governors halted plans to reopen their state economies in the face of a surge in cases.
Almost a quarter of the known global deaths have occurred in the United States – nearly 129,000. A recent surge in cases has put President Donald Trump’s handling of the crisis under a microscope and led several governors to halt plans to reopen their states after strict lockdowns.
Latin America, where Brazil has 1.5 million cases, makes up 23% of the global total of people infected. India has become the new epicenter in Asia, rising to 625,000 cases.
Insurers anticipated a pandemic but could have responded better,says exec
David Williams, managing director of underwriting and technical services at AXA Insurance UK PLC.said the industry’s response to previous virus outbreaks, such as Severe Acute Respiratory Syndrome, or SARS, and the H5N1 avian flu strain, was “why we’ve ended up in a situation where 98% of business interruption policies in the U.K. don’t include the impacts of COVID-19.”
Novartis pays $729 mn to settle US charges that it paid doctors kickbacks
Acting U.S. Attorney Audrey Strauss in Manhattan called the incentives for doctors “nothing more than bribes” and said federal healthcare programs paid hundreds of millions of dollars in reimbursements for prescriptions tainted by kickbacks.
“Giving these cash payments and other lavish goodies interferes with the duty of doctors to choose the best treatment for their patients and increases drug costs for everyone,” Strauss said in a statement.
Coronil: Patanjali can sell its drug, but not as a cure for Covid-19
Baba Ramdev said the Union ministry had asked him to use the term Covid management in place of Covid treatment and he is following the instruction.
Ramdev said the Union ministry had asked him to use the term Covid management in place of Covid treatment and he is following the instruction.
Another COVID-19 wave in 2nd half of 2020 could result in loss of 340 mln full-time jobs: ILO
Regionally, working time losses for the second quarter were: Americas (18.3 per cent), Europe and Central Asia (13.9 per cent), Asia and the Pacific (13.5 per cent), Arab States (13.2 per cent), and Africa (12.1 per cent).
AIIMS partners IIT-Delhi to launch app for patients needing plasma therapy
“This app will act as a bridge between patients seeking plasma therapy and are moderately and severely symptomatic and donors who have recovered from COVID-19 and have completed 28 days post recovery,” Dr Verma explained.
Musk says Tesla is building ‘RNA microfactories’ for CureVac
CureVac, an unlisted German company, has said it is developing transportable, automated mRNA production units that it calls printers. They will be designed to be shipped to remote locations, where they can churn out its vaccine candidate and other mRNA-based therapies depending on the recipe fed into the machine.